Scientific Online Resource System

Annual for Hospital Pharmacy

Patient-Centred Management Of Polypharmacy: A Process For Practice

Nina L Barnett, Lelly Oboh, Katie Smith


Medicines are the most common intervention to improve health. The number of medicines taken by older people in the UK has been steadily increasing for the last three decades. Polypharmacy is a term that refers to either the prescribing or taking many medicines. Concerns about the risks of polypharmacy in primary and secondary care are growing, supported by evidence which associates polypharmacy with increased adverse drug events, hospital admissions, increased healthcare costs and nonadherence. In the UK, this can largely be attributed, over the last 20 years, to the greater availability of evidencebased treatments promoted through therapeutic guidelines which are designed for single conditions, rather than addressing the multimorbidity that affects many older people. There is also currently a paucity of evidence-based national guidance around reducing and stopping medication and incorporating the patient perspective. This paper reviews current UK literature around polypharmacy including a description of four key resources which all make use of international literature and all focus on the medication aspects of polypharmacy from a clinician`s perspective. The patient-centred approach combines both clinical health professionals and patient perspective. Developed using existing resources, it is designed to assist with collaborative (patient and clinician based) medication review to inform decisions around deprescribing and address polypharmacy as part of overall strategies to optimise medicines for the patient. Presented as a diagrammatic representation in seven steps, it also includes guidance on points to consider, actions to take and questions to ask in order to reduce polypharmacy and undertake deprescribing safely.

Full Text


NHS Scotland and The Scottish Government. Polypharmacy Guidance, October 2012. 20guidance%20v2.pdf

Barber N, Alldred DP, Raynor DK, et al. Care homes` use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people.

NHS Wales Health Board. Polypharmacy: Guidance for Prescribing in Frail Adults Practical guide, full guidance, BNF sections to target. May 2013. 5BMay2013%5D.pdf

Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation making it safe and sound. Kings Fund, 2013. polypharmacy-and-medicines-optimisation

NHS Scotland and The Scottish Government. Polypharmacy Guidance, March 2015.

Describing deprescribing. Drug and Therapeutics Bulletin 2014;52:25.

Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010;170:1648-54.

O`Mahoney D, O`Connor MN. Pharmacotherapy at the end-of-life. Age Ageing 2011;40:419-22.

Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 2015;175:827-34.

Gnjidic D, Le Couteur DG, Pearson SA, et al. High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health 2013;13:115.

Jyrkkä J, Enlund H, Korhonen MJ, et al. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 2009;26:1039-48.

Jubraj B, Marvin V, Poots AJ, et al. A pilot survey of junior doctors` attitudes and awareness around medication review: time to change our educational approach? Eur J Hosp Pharm Sci Pract 2015;22:243-8. and http:// (accessed 23 Jul 2015).

Royal Pharmaceutical Society. Medicines Optimisation: Helping patients to make the most of medicines. Good practice Guidance for healthcare professionals in England. May 2013.



Article Tools
Email this article (Login required)